Live-cell imaging of cell-to-cell variability in caspase-8 FRET reporter activity and cell fate trajectory modeling - Dataset (ID:20232)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein | Protein Concentration | Protein Conc Unit | Antibody Name | Antibody Concentration | Antibody Conc Unit | 2nd Antibody Name | 2nd Antibody Concentration | 2nd Antibody Conc Unit | Replicate | Mean log10(k) (a.u.) | Mean tau (min) | Surviving Fraction | Classification Accuracy (theta_T) | Classification Accuracy (fate boundary) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HeLa ICRP | Mapatumumab | 2.5 | nM | anti-Fc | 2.5 | nM | 1 | -5.02 | 168.6104 | 0.582 | 0.83117 | 0.71688 | ||||||
| HeLa ICRP | Mapatumumab | 2.5 | nM | anti-Fc | 2.5 | nM | 2 | -5.14 | 181.8431 | 0.494 | 0.90000 | 0.78824 | ||||||
| HeLa ICRP | Mapatumumab | 2.5 | nM | 2 | -5.92 | 272.2074 | 0.816 | 0.88032 | 0.82181 | |||||||||
| HeLa ICRP | Mapatumumab | 2.5 | nM | 1 | -5.58 | 245.7329 | 0.779 | 0.89251 | 0.83713 | |||||||||
| HeLa ICRP | Mapatumumab | 5.0 | nM | anti-Fc | 5.0 | nM | 1 | -4.80 | 134.6580 | 0.476 | 0.71010 | 0.61238 | ||||||
| HeLa ICRP | Mapatumumab | 5.0 | nM | anti-Fc | 5.0 | nM | 3 | -4.94 | 145.1482 | 0.550 | 0.82210 | 0.67925 | ||||||
| HeLa ICRP | Mapatumumab | 5.0 | nM | 3 | -5.52 | 227.6629 | 0.754 | 0.90935 | 0.80737 | |||||||||
| HeLa ICRP | Mapatumumab | 5.0 | nM | 1 | -5.33 | 226.3964 | 0.694 | 0.89790 | 0.77778 | |||||||||
| HeLa ICRP | Mapatumumab | 5.0 | nM | 2 | -5.65 | 256.4691 | 0.741 | 0.90123 | 0.83457 | |||||||||
| HeLa ICRP | Mapatumumab | 5.0 | nM | anti-Fc | 5.0 | nM | 2 | -4.93 | 153.1692 | 0.347 | 0.89079 | 0.76445 | ||||||
| HeLa ICRP | Mapatumumab | 10.0 | nM | anti-Fc | 10.0 | nM | 3 | -4.68 | 110.9162 | 0.288 | 0.84817 | 0.79581 | ||||||
| HeLa ICRP | Mapatumumab | 10.0 | nM | anti-Fc | 10.0 | nM | 2 | -4.63 | 107.8715 | 0.406 | 0.74559 | 0.66751 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Mapatumumab | 10.0 | nM | 2 | -5.47 | 319.6967 | 0.075 | 0.86936 | 0.30949 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Mapatumumab | 10.0 | nM | 1 | -5.47 | 338.7050 | 0.034 | 0.89448 | 0.31894 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Mapatumumab | 10.0 | nM | anti-Fc | 10.0 | nM | 1 | -4.70 | 139.7368 | 0.011 | 0.92026 | 0.78469 | |||
| HeLa ICRP | Mapatumumab | 10.0 | nM | 1 | -5.46 | 256.4570 | 0.735 | 0.86093 | 0.77815 | |||||||||
| HeLa ICRP | Mapatumumab | 10.0 | nM | 2 | -5.06 | 184.1346 | 0.542 | 0.81410 | 0.75321 | |||||||||
| HeLa ICRP | Bortezomib | 100 | nM | Mapatumumab | 10.0 | nM | anti-Fc | 10.0 | nM | 2 | -4.93 | 186.2624 | 0.010 | 0.90759 | 0.68812 | |||
| HeLa ICRP | Mapatumumab | 10.0 | nM | 3 | -5.31 | 212.8518 | 0.631 | 0.86432 | 0.75628 | |||||||||
| HeLa ICRP | Mapatumumab | 10.0 | nM | anti-Fc | 10.0 | nM | 1 | -4.49 | 83.0851 | 0.309 | 0.68617 | 0.65691 | ||||||
| HeLa ICRP | Mapatumumab | 25.0 | nM | anti-Fc | 25.0 | nM | 3 | -4.54 | 92.8286 | 0.238 | 0.83860 | 0.78369 | ||||||
| HeLa ICRP | Mapatumumab | 25.0 | nM | anti-Fc | 25.0 | nM | 2 | -4.55 | 92.1239 | 0.381 | 0.66372 | 0.64307 | ||||||
| HeLa ICRP | Mapatumumab | 25.0 | nM | anti-Fc | 25.0 | nM | 1 | -4.50 | 85.1585 | 0.268 | 0.73592 | 0.70775 | ||||||
| HeLa ICRP | Mapatumumab | 25.0 | nM | 3 | -5.13 | 188.8499 | 0.479 | 0.88378 | 0.76029 | |||||||||
| HeLa ICRP | Mapatumumab | 25.0 | nM | 1 | -5.21 | 212.5904 | 0.659 | 0.86345 | 0.76707 |